Literature DB >> 19507805

Pharmacological management of cancer pain.

Marcos L Montagnini1, Carolyn R Zaleon.   

Abstract

Pain is one of the most common symptoms experienced by cancer patients during the course of their illness. It can negatively impact patients' quality of life, functional status, and progress during rehabilitation. Despite the widespread availability of analgesic therapies, cancer pain remains undertreated. Developing knowledge and skills on cancer pain management is of extreme importance for healthcare providers dealing with cancer patients. The goal of this article is to review the principles of pharmacological therapy of cancer pain, to describe the basic pathophysiological mechanisms and etiologies of cancer pain, and to highlight the elements of a thorough pain assessment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19507805     DOI: 10.5055/jom.2009.0010

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  4 in total

1.  Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.

Authors:  Juan Miguel Jimenez-Andrade; Joseph R Ghilardi; Gabriela Castañeda-Corral; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2011-09-09       Impact factor: 6.961

2.  [Spinal cord stimulation at the level of the conus medullaris : treatment option for therapy-resistant postoperative neuralgia of the pudendal nerve].

Authors:  R Reichart; S A Kuhn; I Vogel; J Walter; R Kalff
Journal:  Schmerz       Date:  2009-12       Impact factor: 1.107

3.  Evidence of the Involvement of Spinal EZH2 in the Development of Bone Cancer Pain in Rats.

Authors:  Haoming Chen; Jianmang Yu; Lihua Hang; Shuai Li; Weikang Lu; Zhenkai Xu
Journal:  J Pain Res       Date:  2021-11-23       Impact factor: 3.133

4.  Behavioral and neurochemical analysis of ongoing bone cancer pain in rats.

Authors:  Bethany Remeniuk; Devki Sukhtankar; Alec Okun; Edita Navratilova; Jennifer Y Xie; Tamara King; Frank Porreca
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.